270 related articles for article (PubMed ID: 16567864)
21. Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency.
Chen RF; Yang KD; Wang L; Liu JW; Chiu CC; Cheng JT
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1106-13. PubMed ID: 17764712
[TBL] [Abstract][Full Text] [Related]
22. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
Kurane I
Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
[TBL] [Abstract][Full Text] [Related]
23. Implications of dynamic changes among tumor necrosis factor-alpha (TNF-alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection.
Wang L; Chen RF; Liu JW; Yu HR; Kuo HC; Yang KD
Am J Trop Med Hyg; 2007 Aug; 77(2):297-302. PubMed ID: 17690402
[TBL] [Abstract][Full Text] [Related]
24. [The significance of soluble vascular cell adhesion molecule-1 and its relationship with tumor necrosis factor-alpha and interferon-gamma in patients with pulmonary tuberculosis].
Liang Y; Dong DQ; Yang YH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):266-9. PubMed ID: 16750045
[TBL] [Abstract][Full Text] [Related]
25. Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation.
Houghton-Triviño N; Salgado DM; Rodríguez JA; Bosch I; Castellanos JE
J Gen Virol; 2010 Mar; 91(Pt 3):697-706. PubMed ID: 19889931
[TBL] [Abstract][Full Text] [Related]
26. Studies on dengue and dengue haemorrhagic fever (DHF) in West Bengal State, India.
Hati AK
J Commun Dis; 2006 Mar; 38(2):124-9. PubMed ID: 17370674
[TBL] [Abstract][Full Text] [Related]
27. Tumour necrosis factor gene polymorphism in dengue infection: association with risk of bleeding.
Chuansumrit A; Anantasit N; Sasanakul W; Chaiyaratana W; Tangnararatchakit K; Butthep P; Chunhakan S; Yoksan S
Paediatr Int Child Health; 2013 May; 33(2):97-101. PubMed ID: 23925283
[TBL] [Abstract][Full Text] [Related]
28. Relationship of thrombopoietin and interleukin-11 levels to thrombocytopenia associated with dengue disease.
Cardier JE; Balogh V; Perez-Silva C; Romano E; Rivas B; Bosch N; Rothman AL
Cytokine; 2006 May; 34(3-4):155-60. PubMed ID: 16759877
[TBL] [Abstract][Full Text] [Related]
29. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study.
Priyadarshini D; Gadia RR; Tripathy A; Gurukumar KR; Bhagat A; Patwardhan S; Mokashi N; Vaidya D; Shah PS; Cecilia D
PLoS One; 2010 Jan; 5(1):e8709. PubMed ID: 20090849
[TBL] [Abstract][Full Text] [Related]
30. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
31. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand.
Wichmann O; Hongsiriwon S; Bowonwatanuwong C; Chotivanich K; Sukthana Y; Pukrittayakamee S
Trop Med Int Health; 2004 Sep; 9(9):1022-9. PubMed ID: 15361117
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever.
Tseng CS; Lo HW; Teng HC; Lo WC; Ker CG
FEMS Immunol Med Microbiol; 2005 Jan; 43(1):99-102. PubMed ID: 15607642
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor alpha promoter polymorphisms in Mexican patients with dengue fever.
García-Trejo AR; Falcón-Lezama JA; Juárez-Palma L; Granados J; Zúñiga-Ramos J; Rangel H; Barquera R; Vargas-Alarcón G; Ramos C
Acta Trop; 2011; 120(1-2):67-71. PubMed ID: 21693096
[TBL] [Abstract][Full Text] [Related]
34. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
[TBL] [Abstract][Full Text] [Related]
35. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection.
Kittigul L; Pitakarnjanakul P; Sujirarat D; Siripanichgon K
J Clin Virol; 2007 Jun; 39(2):76-81. PubMed ID: 17507286
[TBL] [Abstract][Full Text] [Related]
36. Haematological and biochemical indicators for the early diagnosis of dengue viral infection.
Butt N; Abbassi A; Munir SM; Ahmad SM; Sheikh QH
J Coll Physicians Surg Pak; 2008 May; 18(5):282-5. PubMed ID: 18541082
[TBL] [Abstract][Full Text] [Related]
37. The relationship of systemic TNF-alpha and IFN-gamma with IVF treatment outcome and peripheral blood NK cells.
Thum MY; Abdalla HI; Bhaskaran S; Harden EL; Ford B; Sumar N; Shehata H; Bansal A
Am J Reprod Immunol; 2007 Mar; 57(3):210-7. PubMed ID: 17295900
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress in severe dengue viral infection: association of thrombocytopenia with lipid peroxidation.
Soundravally R; Sankar P; Bobby Z; Hoti SL
Platelets; 2008 Sep; 19(6):447-54. PubMed ID: 18925513
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity.
Ohga S; Matsuzaki A; Nishizaki M; Nagashima T; Kai T; Suda M; Ueda K
Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):291-8. PubMed ID: 8328642
[TBL] [Abstract][Full Text] [Related]
40. Human immune responses to dengue viruses.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Rothman AL; Livingston PG; Janus J; Ennis FA
Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):658-62. PubMed ID: 1983049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
